Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Doug Rizzo"'
Autor:
Sumithira Vasu, Shernan G. Holtan, Akiko Shimamura, Todd Burnworth, Shauna Whisenton, Sanderson Adams, Brandon Nuechterlein, Nicole Mortier, Jackie Foster, Nancy DiFronzo, Mary Horowitz, Doug Rizzo, Amy Foley
Publikováno v:
Transplantation and Cellular Therapy. 29:5-9
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN), funded by the National Heart, Lung, and Blood Institute and the National Cancer Institute for more than 2 decades, is focused on improving the outcomes of hematopoietic cell transplan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254528cce946fcd75ffa29252274b5ce
https://doi.org/10.1016/j.jtct.2022.10.016
https://doi.org/10.1016/j.jtct.2022.10.016
Autor:
Rachel Phelan, Min Chen, Caitrin Bupp, Yung-Tsi Bolon, Larisa Broglie, Janet Brunner-Grady, Linda J. Burns, Saurabh Chhabra, Debra Christianson, Rachel Cusatis, Steven M. Devine, Anita D'Souza, Mary Eapen, Mehdi Hamadani, Mary Hengen, Stephanie J. Lee, Amy Moskop, Kristin M. Page, Marcelo Pasquini, Waleska S. Pérez, Marcie Riches, Doug Rizzo, Wael Saber, Stephen R. Spellman, Heather E. Stefanski, Patricia Steinert, Daniel Weisdorf, Mary Horowitz, Jeffery J. Auletta, Bronwen E. Shaw, Mukta Arora
Publikováno v:
Transplant Cell Ther
Hematopoietic cell transplantation (HCT) has been successfully utilized as treatment for many malignant and non-malignant conditions. As supportive care, donor selection, and treatment modalities evolve, documenting HCT trends and outcomes is critica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf19d53c32a84934c6e77fb676236ff
https://pubmed.ncbi.nlm.nih.gov/35447374
https://pubmed.ncbi.nlm.nih.gov/35447374
Autor:
Mouhab Ayas, Salman Naseem Adil, Shinichiro Okamoto, Mary M. Horowitz, Mohamed A. Kharfan-Dabaja, Daniel J. Weisdorf, Asma El Quessar, Tarek Ben Othman, Wael Saber, Dennis L. Confer, Ardeshir Ghavamzadeh, Eliane Gluckman, Mahmoud Aljurf, Amr Nassar, Fazal Hussain, Hassan El Solh, David Dennison, Alok Srivastava, Yoshihisa Kodera, Ali Bazarbachi, Saleh Ladeb, Hossam K. Mahmoud, Peihua Lu, Greinix Hildegard, Nickolas Novitzky, Syed Osman Ahmed, Parvez Ahmed, Doug Rizzo, Dietger Niederwieser, Jeff Szer, Parameswaran Hari, Mehdi Hamadani, Rose Marie Hamladji, Abdelghani Tbakhi, Amir Ali Hamidieh, Mohamed Amine Bekadja, Navneet S. Majhail, Adriana Seber, Alaa Elhaddad, Mohamad Mohty, Yoshiko Atsuta, Salman Alkindi, Marcelo C. Pasquini, Shahrukh K. Hashmi, Moosa Patel, Ayman Alhejazi, Usama Gerges
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2330-2337
The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ea93cafcc8b20bf58af4b00a414b30
https://doi.org/10.1016/j.bbmt.2019.04.012
https://doi.org/10.1016/j.bbmt.2019.04.012
Autor:
Christina Ullrich, Alison W. Loren, Gloria Gee, Bronwen E. Shaw, Beatrice Abbetti, Barry A. Schatz, C. Fred LeMaistre, Susan Doughtie, Theresa Hahn, Elizabeth Murphy, David J. Vanness, Linda J. Burns, Navneet S. Majhail, Lakshmanan Krishnamurit, Ellen M. Denzen, Mark B. Juckett, Susan Kullberg, Areej El-Jawahiri, Stacie D. Arnold, Doug Rizzo, Jeff B. Bender, Karen L. Syrjala, D. Kathryn Tierney, Mary M. Horowitz, William A. Wood, Shirley Johnson, Wael Saber, Alva Roche-Green, Kim Schmit-Pokorny
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(6)
The goal of patient-centered outcomes research (PCOR) is to help patients and those who care for them make informed decisions about healthcare. However, the clinical research enterprise has not involved patients, caregivers, and other non-providers r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c246a542c62fae2e055ff032c5895462
https://pubmed.ncbi.nlm.nih.gov/29408289
https://pubmed.ncbi.nlm.nih.gov/29408289
Hematopoietic cell transplant survivors face a number of challenges including low energy and stamina, "chemo-brain" and emotional distress, and late effects that can compromise functioning or lead to early mortality. This session will review the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b0c7eeeda71ce29062d429d9a6f51d5
https://europepmc.org/articles/PMC3445407/
https://europepmc.org/articles/PMC3445407/
Autor:
John Barrett, Hillard M. Lazarus, Marcelo C. Pasquini, Brenda M. Sandmaier, Mary M. Horowitz, Andrea Bacigalupo, Jane F. Apperley, Vincent T. Ho, Doug Rizzo, Shimon Slavin, Sergio Giralt, Didier Blaise, Robert Lowski, Karen K. Ballen
Publikováno v:
Biology of Blood and Marrow Transplantation. (12):1628-1633
Defining conditioning regimen intensity has become a critical issue for the hemopoietic stem cell transplant (HSCT) community. In the present report we propose to define conditioning regimens in 3 categories: (1) myeloablative (MA) conditioning, (2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d0cb8a61cd375e4b49583cd72d164e